Atlantic Edge Private Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Sell
4,833
-1,413
-23% -$678K 0.5% 47
2026
Q1
$3.07M Sell
6,246
-35
-0.6% -$19K 0.75% 32
2025
Q4
$3.64M Buy
6,281
+1,248
+25% +$706K 0.9% 30
2025
Q3
$2.44M Buy
5,033
+70
+1% +$32.6K 0.63% 42
2025
Q2
$2.01M Sell
4,963
-85
-2% -$35.5K 0.55% 47
2025
Q1
$2.51M Hold
5,048
0.77% 34
2024
Q4
$2.63M Buy
5,048
+1
+0% +$550 0.81% 30
2024
Q3
$3.12M Buy
5,047
+110
+2% +$65.1K 0.95% 24
2024
Q2
$2.73M Buy
4,937
+15
+0.3% +$8.59K 0.91% 24
2024
Q1
$2.86M Buy
4,922
+167
+4% +$93.7K 0.98% 24
2023
Q4
$2.52M Buy
+4,755
New +$2.3M 1.03% 23

Other funds holding TMO

Atlantic Edge Private Wealth Management's TMO Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 23% in Q2 2026, selling an estimated $678K and leaving 4,833 shares worth $2.42M. The position accounts for 0.5% of the portfolio, ranked #47.

Atlantic Edge Private Wealth Management first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.64M in Q4 2025. 966 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Atlantic Edge Private Wealth Management held 4,833 shares of Thermo Fisher Scientific worth $2.42M as of Q2 2026.
  • Atlantic Edge Private Wealth Management sold 1,413 Thermo Fisher Scientific shares in Q2 2026, an estimated $678K.
  • Thermo Fisher Scientific made up 0.5% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #47 holding.
  • Atlantic Edge Private Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Atlantic Edge Private Wealth Management's Thermo Fisher Scientific position peaked at $3.64M in Q4 2025.
  • 966 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.